Trials / Completed
CompletedNCT00912015
A Comparison of the Analgesic Efficacy and Safety of Once Daily Tramadol OAD Tablets to Twice Daily Tramadol BID for the Treatment of Osteoarthritis of the Knee (Extension Protocol) and Open Label Safety Follow-Up
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 238 (actual)
- Sponsor
- Labopharm Inc. · Industry
- Sex
- All
- Age
- 40 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the long-term safety (up to one year) of Tramadol Once-A-Day (OAD) tablets at the highest doses: 200-400 mg
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tramadol OAD | |
| DRUG | Tramadol OAD | |
| DRUG | Tramadol OAD | |
| DRUG | Tramadol OAD 100mg |
Timeline
- Start date
- 2002-03-01
- Primary completion
- 2003-07-01
- Completion
- 2003-07-01
- First posted
- 2009-06-03
- Last updated
- 2012-04-30
- Results posted
- 2009-06-03
Source: ClinicalTrials.gov record NCT00912015. Inclusion in this directory is not an endorsement.